Skip to main content

Humana Inc(HUM-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low171.96
Day High179.98
Open:179.71
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Humana Inc

Select a category then submit the form to load news
Tipranks
Humana Issues $1 Billion Junior Subordinated Notes Offering
Zacks Investment Research
UNH Deploys AI in Optum Rx to Tackle Pharmacy Fraud and Cost Leakage
UNH Deploys AI in Optum Rx to Tackle Pharmacy Fraud and Cost Leakage
Tipranks
Humana Reaffirms 2026 Earnings Guidance in Investor Meetings
Tipranks
Jefferies Keeps Their Buy Rating on Humana (HUM)
Tipranks
Wells Fargo Sticks to Its Hold Rating for Humana (HUM)
StockStory
3 Reasons HUM Has Explosive Upside Potential
HUM
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Summit Therapeutics (SMMT) and Intuitive Surgical (ISRG)
Tipranks
Goldman Sachs Keeps Their Sell Rating on Humana (HUM)
Motley Fool
Naya Capital Adds Masimo Shares
Tipranks
Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD), Humana (HUM) and Palvella Therapeutics (PVLA)
Tipranks
Analysts Conflicted on These Healthcare Names: Ansell (OtherANSLF), Moderna (MRNA) and Humana (HUM)
Tipranks
Truist Financial Reaffirms Their Hold Rating on Humana (HUM)
Tipranks
Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), Humana (HUM) and 10x Genomics (TXG)
Stock Target Advisor
CPI Reduction Calms Inflation Fears-Market Analysis for February 13th, 2026
CPI Reduction Calms Inflation Fears-Market Analysis for February 13th, 2026
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Humana (HUM)
Tipranks
Jefferies Reaffirms Their Buy Rating on Humana (HUM)
Tipranks
UBS Keeps Their Hold Rating on Humana (HUM)
Tipranks
Cantor Fitzgerald Reaffirms Their Hold Rating on Humana (HUM)
Tipranks
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Humana (HUM)
Tipranks
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Humana (HUM)
Tipranks
Barclays Keeps Their Hold Rating on Humana (HUM)
Tipranks
Analysts Offer Insights on Healthcare Companies: Humana (HUM), Tenet Healthcare (THC) and Stoke Therapeutics (STOK)
Tipranks
Humana Earnings Call: Growth Prospects Versus STARS Hit
Stock Target Advisor
Jobs Beat and AI Disruption Concerns Hit Stocks-Market Analysis for February 11th, 2026
Jobs Beat and AI Disruption Concerns Hit Stocks-Market Analysis for February 11th, 2026
Motley Fool
Humana (HUM) Q4 2025 Earnings Call Transcript
StockStory
Humana (NYSE:HUM) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops
HUM
StockStory
Humana (HUM) Q4 Earnings: What To Expect
HUM
Motley Fool
Medicare Changes in 2026 Every Retiree Needs to Know: The Good, the Bad, and the Ugly
Zacks Investment Research
Will Declining Medical Membership Affect Humana's Q4 Earnings?
Will Declining Medical Membership Affect Humana's Q4 Earnings?
StockStory
1 Oversold Stock Set for a Comeback and 2 We Brush Off
BOX
Tipranks
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Synergy CHC (SNYR) and Humana (HUM)
StockStory
1 S&P 500 Stock for Long-Term Investors and 2 We Brush Off
VZ

Profile

Humana Inc. is a health care plan provider in the United States. The company provides health insurance benefits under Health Maintenance Organization, Private Fee-For-Service and Preferred Provider Organization plans. The company also provides other benefits with specialty products including dental, vision, and other supplementary benefits. Humana's medical and specialty insurance products allow members to access health care services primarily through its networks of health care providers. The company manages its business through the following segments: The Retail segment consists of Medicare benefits, which are marketed on a retail basis to individuals. The Group and Specialty segment comprises employer group commercial fully-insured medical and specialty health insurance benefits. The Healthcare Services - The segment consists of services offered to the company's health plan members as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.